BruceWelshBodeMD

Endocrinology • Atlanta, GA

Endocrinologist at Atlanta Diabetes Associates

Join to view full profile

Dr. Bode is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bode's full profile

Already have an account?

Office
1800 Howell Mill Road
Suite 450
Atlanta, GA 30318
Phone+1 404-355-4393

Fax+1 404-419-9852
Is this information wrong?

Education & Training

Emory University School of MedicineResidency, Internal Medicine, 1981 - 1984
Emory University School of MedicineClass of 1981

Certifications & Licensure

GA State Medical License 1982 - 2025
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Top MD Consumers Checkbook
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU Start of enrollment: 2006 Jun 01
Completed
Not Applicable
A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port Start of enrollment: 2006 Oct 01
Completed
Not Applicable
Glucose Meter Study Start of enrollment: 2008 Nov 01
Completed
Not Applicable
Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes Start of enrollment: 2008 Feb 01
Completed
Not Applicable
A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01
Withdrawn
Phase 2
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus Start of enrollment: 2012 May 01
Completed
Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277® Start of enrollment: 2013 Oct 01
Terminated
Phase 3
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System Start of enrollment: 2014 Feb 01
Completed
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus Start of enrollment: 2014 Mar 01
Terminated
Phase 2
In Clinic Evaluation of the PLGM Feature Start of enrollment: 2014 Oct 01
Completed
Not Applicable
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes Start of enrollment: 2015 Jun 01
Completed
Not Applicable
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
T1 Diabetes Hypoglycemia Prevention Pilot Start of enrollment: 2016 May 01
Terminated
Not Applicable
A Study of LY3209590 in Participants With Type 1 Diabetes Start of enrollment: 2020 Jul 06
Completed
Phase 2
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes Start of enrollment: 2020 Oct 30
Completed
Phase 2
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) Start of enrollment: 2020 Nov 04
Completed
Phase 3
Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes Start of enrollment: 2020 Nov 23
Completed
Not Applicable
A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes Start of enrollment: 2020 Sep 15
Completed
Early Phase 1
Use of the Guardian™ Connect System With Smart Connected Devices Start of enrollment: 2021 Apr 06
Completed
Not Applicable
Evaluation of Medtronic DUO Extended Set Start of enrollment: 2021 Mar 18
Recruiting
Not Applicable
Eversense® Non-adjunctive Use Post Approval Study Start of enrollment: 2021 Apr 13
Recruiting
Not Applicable
Roles: Principal Investigator
A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function Start of enrollment: 2020 Dec 21
Active, not recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes.
Richard M Bergenstal, Bruce W Bode, Anuj Bhargava, Qianqian Wang, Alastair W Knights, Annette M Chang> ;Diabetes Therapy. 2023 Nov 1
2 citations
Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range.
Timothy S Bailey, Bruce W Bode, Qianqian Wang, Alastair W Knights, Annette M Chang> ;Diabetes Therapy. 2023 May 1
86 citations
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
Anders L. Carlson, Jennifer L. Sherr, Dorothy I. Shulman, Satish K. Garg, Rodica Pop-Busui, Bruce W. Bode, David R. Lilenquist, Ron Brazg, Kevin B. Kaiserman, Mark Kip...> ;Diabetes Technology & Therapeutics. 2021 Nov 16
64 citations
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy.
Eli Ipp, David R. Liljenquist, Bruce W. Bode, Viral N. Shah, Steven Silverstein, Carl D. Regillo, Jennifer I. Lim, Srinivas R. Sadda, Amitha Domalpally, Gerry Gray, Ma...> ;JAMA Network Open. 2021 Nov 1
2 citations
T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications
Paul Minh Huy Tran, Eileen Kim, Lynn Kim Hoang Tran, bin Satter Khaled, Diane Hopkins, Melissa Gardiner, Jennifer Bryant, Risa Bernard, John C. Morgan, Bruce W. Bode, ...> ;International Journal of Environmental Research and Public Health. 2021 Oct 21
30 citations
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
Satish K. Garg, David R. Liljenquist, Bruce W. Bode, Mark P. Christiansen, Timothy S. Bailey, Ronald L. Brazg, Douglas S Denham, Anna R Chang, Halis Kaan Akturk, Andre...> ;Diabetes Technology & Therapeutics. 2021 Sep 9
2 citations
Clinical Evaluation of a Novel CGM-Informed Bolus Calculator with Automatic Glucose Trend Adjustment.
Jordan E. Pinsker, Mei Mei Church, Sue A. Brown, Mary K. Voelmle, Bruce W. Bode, Brooke Narron, Lauren M. Huyett, Joon Bok Lee, Jason O'Connor, Eric Benjamin, Bonnie D...> ;Diabetes Technology & Therapeutics. 2021 Sep 3
13 citations
Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System.
Bruce W. Bode, Anders E. Carlson, Rong Liu, Thomas Hardy, Richard M. Bergenstal, Jennifer Boyd, Scott Morrett, Debra A. Ignaut> ;Diabetes Technology & Therapeutics. 2021 Jul 16
20 citations
Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2
Mark Warren, Bruce W. Bode, Jang Ik Cho, Rong Liu, Janet Tobian, Thomas Hardy, Farai Chigutsa, Moshe Phillip, Barry Horowitz, Debra A. Ignaut> ;Diabetes, Obesity & Metabolism. 2021 Jul 1
3 citations
Leveraging advances in diabetes technologies in primary care: a narrative review.
Bruce W. Bode, Aaron King, David Russell-Jones, Liana K. Billings> ;Annals of Medicine. 2021 Jun 29
107 citations
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode, Jordan E. Pinsker, Carol J. Levy, Amy Criego, David W Hansen, Irl B. Hirsch, Anders L. Carlson, Richard M. Bergenstal...> ;Diabetes Care. 2021 Jun 7
107 citations
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
George Grunberger, Jennifer L. Sherr, Myriam Allende, Thomas Blevins, Bruce W. Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, Victor L. Roberts, David Rod...> ;Endocrine Practice. 2021 Jun 1
Continuous and Intermittent Glucose Monitoring in 2020
Bruce W. Bode, Tadej Battelino, Klemen Dovc> ;Diabetes Technology & Therapeutics. 2021 May 31
23 citations
An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HbA1c
Roy W. Beck, Laura E. Bocchino, John Lum, Craig Kollman, Victoria Barnes-Lomen, Mark Sulik, Michael J. Haller, Bruce W. Bode, Joseph T. Cernich, Anthony A. Killeen, Ut...> ;Diabetes Technology & Therapeutics. 2021 Apr 7
66 citations
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-c...
Matthias von Herrath, Stephen C. Bain, Bruce W. Bode, Jesper Ole Clausen, Ken Coppieters, Leylya Gaysina, Janusz Gumprecht, Troels Krarup Hansen, Chantal Mathieu, Cris...> ;The Lancet. Diabetes & Endocrinology. 2021 Apr 1
6 citations
Serum Levels of Inflammatory Proteins Are Associated With Peripheral Neuropathy in a Cross-Sectional Type-1 Diabetes Cohort.
Sharad Purohit, Paul Minh Huy Tran, Lynn Kim Hoang Tran, Khaled Bin Satter, Mingfang He, Wenbo Zhi, Shan Bai, Diane Hopkins, Melissa Gardiner, Chandramohan G. Wakade, ...> ;Frontiers in Immunology. 2021 Mar 31
40 citations
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes.
Gregory P. Forlenza, Bruce A. Buckingham, Sue A. Brown, Bruce W. Bode, Carol J. Levy, Amy Criego, R. Paul Wadwa, Erin Cobry, Robert J. Slover, Laurel H. Messer, Cari B...> ;Diabetes Technology & Therapeutics. 2021 Jan 18
20 citations
Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study.
Bruce W. Bode, Satish K. Garg, Paul Norwood, Cristobal Morales, Thomas Hardy, Rong Liu, Debra A. Ignaut> ;Diabetes Technology & Therapeutics. 2021 Jan 1
5 citations
Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes.
Sanjeev N. Mehta, Liane J. Tinsley, Davida F. Kruger, Bruce W. Bode, Jennifer E. Layne, Lauren M. Huyett, Kate Dryga, Bonnie Dumais, Trang T. Ly, Lori M. Laffel> ;Clinical Diabetes. 2021 Jan 1
11 citations
Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study
Bruce W. Bode, Eda Cengiz, R. Paul Wadwa, Phillip Banks, Thomas Danne, Jake A. Kushner, Darren K. McGuire, Anne L. Peters, Paul Strumph, Sangeeta Sawhney> ;Diabetes Technology & Therapeutics. 2021 Jan 1
14 citations
Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomi...
John B. Buse, Bruce W. Bode, Ann Mertens, Young Min Cho, Erik Christiansen, Christin L. Hertz, Morten Nielsen, Thomas R. Pieber> ;BMJ Open Diabetes Research & Care. 2020 Dec 1
156 citations
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Richard E. Pratley, Lauren Kanapka, Michael R. Rickels, Andrew J. Ahmann, Grazia Aleppo, Roy W. Beck, Anuj Bhargava, Bruce W. Bode, Anders E. Carlson, Naomi Chaytor, D...> ;JAMA. 2020 Jun 16
18 citations
Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
Maciej T. Malecki, Dachuang Cao, Rong Liu, Thomas Hardy, Bruce W. Bode, Richard M. Bergenstal, Juliana M. Bue-Valleskey> ;Diabetes Technology & Therapeutics. 2020 Nov 9
421 citations
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.
Bruce W. Bode, Valerie Garrett, Jordan Messler, Raymie McFarland, Jennifer Crowe, Robby Booth, David C. Klonoff> ;Journal of Diabetes Science and Technology. 2020 May 9
13 citations
Glycemic responses to strenuous training in male professional cyclists with type 1 diabetes: a prospective observational study.
Olivia McCarthy, Max L. Eckstein, Sam N. Scott, Federico Y. Fontana, Mark P. Christiansen, Christoph Stettler, Miles Fisher, Bruce W. Bode, Michael C. Riddell, Charlot...> ;BMJ Open Diabetes Research & Care. 2020 Apr 1
Join now to see all

Press Mentions

Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More Than 25% in Only Four WeeksJune 15th, 2020
Bruce Bode, MD: Hypoglycemic Effect of Hepatic-Directed InsulinJune 17th, 2019
Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic RetinopathyJune 5th, 2019
Join now to see all

Hospital Affiliations

Piedmont Atlanta HospitalAtlanta, Georgia
Emory Saint Joseph's HospitalAtlanta, Georgia

BruceWelshBodeMD

Dr. Bode is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.